SCHEMBL23947830

SCHEMBL23947830

c1ccc(-c2ccc3c(c2)c2cc(-c4ccc5oc6cc(-c7nc(-c8ccccc8)nc(-c8cccc9oc%10ccccc%10c89)n7)ccc6c5c4)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
MMP12 P39900 2/20 0.33
MMP13 P45452 1/20 0.33
PLA2G10 O15496 1/20 0.33
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
CHEK2 O96017 1/20 0.32
PTGER4 P35408 1/20 0.31
HCRTR1 O43613 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26168497 1.00 PLA2G2A (0.34) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL26168765 0.99 SIRT2 (0.32) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL26169234 0.98 MMP12 (0.34) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL26168528 0.98 MMP12 (0.34) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL26169027 0.98 MMP12 (0.34) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL23947829 0.97 SIRT2 (0.32) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL23947827 0.97 KDM4E (0.35) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL21187385 0.97 KDM4E (0.35) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL23814213 0.97 PLA2G2A (0.33) PLA2G2APLA2G4ASIRT2SIRT1MMP12
SCHEMBL26168892 0.97 MMP12 (0.34) PLA2G2APLA2G4ASIRT2SIRT1MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 PLA2G2A 3489/4885PLA2G4A 3258/4885SIRT2 924/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 PLA2G2A 3492/4885PLA2G4A 3227/4885SIRT2 875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.